These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8761307)

  • 21. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
    Koochekpour S; Jeffers M; Rulong S; Taylor G; Klineberg E; Hudson EA; Resau JH; Vande Woude GF
    Cancer Res; 1997 Dec; 57(23):5391-8. PubMed ID: 9393765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Catenin and actin reorganization in HGF/SF response of ST14A cells.
    Soldati C; Biagioni S; Poiana G; Augusti-Tocco G
    J Neurosci Res; 2008 Apr; 86(5):1044-52. PubMed ID: 17975841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
    Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-expression of the HGF/SF and c-met genes during early mouse embryogenesis precedes reciprocal expression in adjacent tissues during organogenesis.
    Andermarcher E; Surani MA; Gherardi E
    Dev Genet; 1996; 18(3):254-66. PubMed ID: 8631159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased fibronectin expression in Met/HGF-mediated tumorigenesis.
    Taylor GA; Jeffers M; Webb CP; Koo HM; Anver M; Sekiguchi K; Vande Woude GF
    Oncogene; 1998 Sep; 17(9):1179-83. PubMed ID: 9764829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte growth factor/scatter factor-Met signaling induces proliferation, migration, and morphogenesis of pancreatic oval cells.
    Jeffers M; Rao MS; Rulong S; Reddy JK; Subbarao V; Hudson E; Vande Woude GF; Resau JH
    Cell Growth Differ; 1996 Dec; 7(12):1805-13. PubMed ID: 8959349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
    Harvey P; Warn A; Newman P; Perry LJ; Ball RY; Warn RM
    J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity.
    Bellusci S; Moens G; Gaudino G; Comoglio P; Nakamura T; Thiery JP; Jouanneau J
    Oncogene; 1994 Apr; 9(4):1091-9. PubMed ID: 8134112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the met/hepatocyte growth factor/scatter factor receptor and its ligand during differentiation of murine P19 embryonal carcinoma cells.
    Yang XM; Park M
    Dev Biol; 1993 Jun; 157(2):308-20. PubMed ID: 8388815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development.
    Théry C; Sharpe MJ; Batley SJ; Stern CD; Gherardi E
    Dev Genet; 1995; 17(1):90-101. PubMed ID: 7554499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
    Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
    Naim R; Tolnay E; Mueller KM; Kuhnen C
    Int J Mol Med; 2004 Nov; 14(5):787-91. PubMed ID: 15492846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. met and HGF-SF in normal melanocytes and melanoma cells.
    Halaban R; Rubin JS; White W
    EXS; 1993; 65():329-39. PubMed ID: 8380740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.